Study of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
Status:
Recruiting
Trial end date:
2024-12-28
Target enrollment:
Participant gender:
Summary
This study will evaluate the effects of different doses of Lu AG13909 in adult participants
with congenital adrenal hyperplasia, also called CAH. CAH is a rare genetic disorder that
affects a person's ability to produce certain hormones. The main goals of this study are to
learn about the safety and tolerability of Lu AG13909, how Lu AG13909 behaves in the body,
and how the body responds to Lu AG13909.